Keyphrases
3-cycle
20%
Anthracyclines
100%
Biopsy Specimen
20%
Breast Cancer Patients
60%
Chemoresistance
20%
Clinical Response
60%
Confidence Interval
40%
Expression Response
20%
Immunohistochemical Analysis
20%
Invasive Ductal
20%
Locally Advanced Breast Cancer
100%
Luminal B Subtype
20%
Nave
20%
Neoadjuvant Chemotherapy
100%
Non-associated
20%
Overall Survival
20%
P-glycoprotein (P-gp)
100%
P-glycoprotein Expression
100%
Pathological Complete Response
20%
Pathological Response
60%
Patient Response
20%
Post-neoadjuvant
20%
Predictive Factors
20%
Prospective Cohort Study
20%
Relative Risk
40%
Response to Neoadjuvant Chemotherapy
20%
Medicine and Dentistry
ABC Transporter Subfamily B
100%
Anthracycline
100%
Biopsy Sample
12%
Drug Resistance
12%
Immunohistochemistry
12%
Locally Advanced Breast Cancer
100%
Neoadjuvant Chemotherapy
100%
Overall Survival
12%
Predictive Factor
12%
Prospective Cohort Study
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anthracycline
100%
Breast Cancer
100%
Chemotherapy
100%
Drug Resistance
12%
Overall Survival
12%
P-Glycoprotein
100%
Prospective Cohort Study
12%
Biochemistry, Genetics and Molecular Biology
Anthracycline
100%
Drug Resistance
12%
Overall Survival
12%
P-Glycoprotein
100%
Prospective Cohort Study
12%
Neuroscience
ABC Transporter Subfamily B
100%
Anthracycline
100%
Drug Resistance
12%
Immunohistochemistry
12%